PGNX - Progenics Pharmaceuticals Inc. (PGNX) CEO Mark Baker on Q4 2018 Results - Earnings Call Transcript
Progenics Pharmaceuticals, Inc. (PGNX)
Q4 2018 Earnings Conference Call
March 14, 2019 08:30 AM ET
Company Participants
Melissa Downs - Associate Director, Investor Relations
Mark Baker - Chief Executive Officer
Bryce Tenbarge - Senior Vice President of Commercial
Pat Fabbio - Executive Vice President & Chief Financial Officer
Conference Call Participants
Martin Auster - Credit Suisse
Chad Messer - Needham & Company
Tim Chiang - BTIG
Biren Amin - Jefferies
Presentation
Operator
Good day, ladies and gentlemen and welcome to the Progenics Pharmaceuticals Fourth Quarter 2018 Results Conference Call. At this time, all participants are